Myovant Sciences MYOV Stock
Myovant Sciences Price Chart
Myovant Sciences MYOV Financial and Trading Overview
| Myovant Sciences stock price | 26.98 USD |
| Previous Close | 26.99 USD |
| Open | 26.99 USD |
| Bid | 0 USD x 28000 |
| Ask | 0 USD x 1400 |
| Day's Range | 26.98 - 27 USD |
| 52 Week Range | 7.67 - 27.06 USD |
| Volume | 2.26M USD |
| Avg. Volume | 1.12M USD |
| Market Cap | 2.62B USD |
| Beta (5Y Monthly) | 2.154682 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 27 USD |
MYOV Valuation Measures
| Enterprise Value | 2.72B USD |
| Trailing P/E | N/A |
| Forward P/E | -26.194176 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 6.9215994 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 7.164 |
| Enterprise Value/EBITDA | -18.656 |
Trading Information
Myovant Sciences Stock Price History
| Beta (5Y Monthly) | 2.154682 |
| 52-Week Change | 87.75% |
| S&P500 52-Week Change | 2.65% |
| 52 Week High | 27.06 USD |
| 52 Week Low | 7.67 USD |
| 50-Day Moving Average | 26.92 USD |
| 200-Day Moving Average | 21.54 USD |
MYOV Share Statistics
| Avg. Volume (3 month) | 1.12M USD |
| Avg. Daily Volume (10-Days) | 1.68M USD |
| Shares Outstanding | 97.26M |
| Float | 50.86M |
| Short Ratio | 11.21 |
| % Held by Insiders | 48.61% |
| % Held by Institutions | 56.21% |
| Shares Short | 8.39M |
| Short % of Float | 17.89% |
| Short % of Shares Outstanding | 8.63% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | March 31, 2023 |
Profitability
| Profit Margin | -48.47% |
| Operating Margin (ttm) | -38.75% |
| Gross Margin | 44.69% |
| EBITDA Margin | -38.39% |
Management Effectiveness
| Return on Assets (ttm) | -18.22% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 379.11M USD |
| Revenue Per Share (ttm) | 3.96 USD |
| Quarterly Revenue Growth (yoy) | 84.09% |
| Gross Profit (ttm) | 72.02M USD |
| EBITDA | -145576992 USD |
| Net Income Avi to Common (ttm) | -183770000 USD |
| Diluted EPS (ttm) | -1.92 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 274.44M USD |
| Total Cash Per Share (mrq) | 2.82 USD |
| Total Debt (mrq) | 366.88M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.573 |
| Book Value Per Share (mrq) | -5.752 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -269868992 USD |
| Levered Free Cash Flow (ttm) | -149162624 USD |
Profile of Myovant Sciences
| Country | United States |
| State | N/A |
| City | London |
| Address | 11-12 St. James’s Square |
| ZIP | SW1Y 4LB |
| Phone | 44 20 7400 3351 |
| Website | https://myovant.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 579 |
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. It is also developing MVT-602, an oligopeptide kisspeptin agonist, which is in Phase II clinical trial for the treatment of female infertility as part of assisted reproduction. Myovant Sciences Ltd. has collaboration with Pfizer Inc. to develop and commercialize relugolix in oncology and women's health. The company was formerly known as Roivant Endocrinology Ltd. and changed its name to Myovant Sciences Ltd. in May 2016. The company was incorporated in 2016 and is based in London, the United Kingdom. Myovant Sciences Ltd. is a subsidiary of Sumitovant Biopharma Ltd.
Q&A For Myovant Sciences Stock
What is a current MYOV stock price?
Myovant Sciences MYOV stock price today per share is 26.98 USD.
How to purchase Myovant Sciences stock?
You can buy MYOV shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Myovant Sciences?
The stock symbol or ticker of Myovant Sciences is MYOV.
Which industry does the Myovant Sciences company belong to?
The Myovant Sciences industry is Biotechnology.
How many shares does Myovant Sciences have in circulation?
The max supply of Myovant Sciences shares is 97.26M.
What is Myovant Sciences Price to Earnings Ratio (PE Ratio)?
Myovant Sciences PE Ratio is 0.00000000 now.
What was Myovant Sciences earnings per share over the trailing 12 months (TTM)?
Myovant Sciences EPS is 0 USD over the trailing 12 months.
Which sector does the Myovant Sciences company belong to?
The Myovant Sciences sector is Healthcare.
Myovant Sciences MYOV included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NYSE COMPOSITE (DJ) NYA | 17639.04 USD — |
-1.54
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}